Case Report: Short-term response to mesenchymal epithelial transition inhibitor/epidermal growth factor receptor tyrosine kinase inhibitor combination in EGFR-mutated non-small cell lung cancer with acquired MET overexpression after progression and discussion on comprehensive management

Xiaofeng Zhou, Niharika Prasad, Sanjay Jaiswal, Kui Wu, Wenzheng Sun, Li Shen, Lihua Wang, Xueping Xiang, Xiaojuan He, Lin Zheng, Chao-Chao Qin

Open source

DOI: 10.3389/fonc.2026.1836074
Published: 2026-07-15
Container: Frontiers in Oncology
Publisher: Frontiers Media SA
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fonc.2026.1836074,
  title = {Case Report: Short-term response to mesenchymal epithelial transition inhibitor/epidermal growth factor receptor tyrosine kinase inhibitor combination in EGFR-mutated non-small cell lung cancer with acquired MET overexpression after progression and discussion on comprehensive management},
  author = {Xiaofeng Zhou and Niharika Prasad and Sanjay Jaiswal and Kui Wu and Wenzheng Sun and Li Shen and Lihua Wang and Xueping Xiang and Xiaojuan He and Lin Zheng and Chao-Chao Qin},
  year = {2026},
  journal = {Frontiers in Oncology},
  doi = {10.3389/fonc.2026.1836074},
  url = {https://doi.org/10.3389/fonc.2026.1836074}
}

RIS

TY  - JOUR
TI  - Case Report: Short-term response to mesenchymal epithelial transition inhibitor/epidermal growth factor receptor tyrosine kinase inhibitor combination in EGFR-mutated non-small cell lung cancer with acquired MET overexpression after progression and discussion on comprehensive management
AU  - Xiaofeng Zhou
AU  - Niharika Prasad
AU  - Sanjay Jaiswal
AU  - Kui Wu
AU  - Wenzheng Sun
AU  - Li Shen
AU  - Lihua Wang
AU  - Xueping Xiang
AU  - Xiaojuan He
AU  - Lin Zheng
AU  - Chao-Chao Qin
PY  - 2026
JO  - Frontiers in Oncology
DO  - 10.3389/fonc.2026.1836074
UR  - https://doi.org/10.3389/fonc.2026.1836074
ER  -

APA

Zhou, X., Prasad, N., Jaiswal, S., Wu, K., Sun, W., Shen, L., Wang, L., Xiang, X., He, X., Zheng, L., & Qin, C. (2026). Case Report: Short-term response to mesenchymal epithelial transition inhibitor/epidermal growth factor receptor tyrosine kinase inhibitor combination in EGFR-mutated non-small cell lung cancer with acquired MET overexpression after progression and discussion on comprehensive management. Frontiers in Oncology. https://doi.org/10.3389/fonc.2026.1836074

Source records

crossref · retrieved 2026-09-27T03:59:44.195Z